PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 92.60
+4.50 (5.11%)
At close: Jan 16, 2026
PsyRX CNS Bio-Tech Market Cap
PsyRX CNS Bio-Tech has a market cap or net worth of 9.47 million as of January 16, 2026. Its market cap has increased by 66.69% in one year.
Market Cap
9.47M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
92.60
Market Cap Chart
Since July 25, 2021, PsyRX CNS Bio-Tech's market cap has decreased from 329.34M to 9.47M, a decrease of -97.12%. That is a compound annual growth rate of -54.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 9.47M | -3.24% |
| Dec 31, 2025 | 9.79M | 100.78% |
| Dec 31, 2024 | 4.87M | -44.97% |
| Dec 31, 2023 | 8.86M | -64.09% |
| Dec 29, 2022 | 24.66M | -59.42% |
| Dec 30, 2021 | 60.77M | -81.55% |
| Jul 25, 2021 | 329.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.65B |
| Bank Leumi le-Israel B.M. | 115.27B |
| Elbit Systems | 104.98B |
| Bank Hapoalim B.M. | 104.62B |
| Mizrahi Tefahot Bank | 64.60B |
| Azrieli Group | 50.92B |
| Israel Discount Bank | 45.38B |
| Phoenix Financial | 36.61B |